TP53 and cancer: Recent studies have demonstrated that the sequential loss of p53 and p73 induces stable EMT and enhances cancer stem cell (CSC) traits by activating the canonical Wnt signaling pathway, contributing to increased tumor aggressiveness and therapeutic resistance [74].